Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children:
|
|
- Bernice Young
- 5 years ago
- Views:
Transcription
1 Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children: Acute Health Outcome M I LTO N T E N E N B E I N, M D U N I V E R S I T Y O F M A N I T O B A 1
2 Disclosure Member of the ILSI North America Caffeine Systematic Review Team ILSI North America provided an honorarium and travel funds to attend this meeting. 2
3 PECO Questions for the Acute Health Outcome For [population], is caffeine intake above [dose], compared to intakes [dose] or less, associated with adverse acute outcomes? Population* Healthy Adults Healthy Adults Exposure > 400 mg/day > 10 g Comparator 400 mg/day 10 g Outcome Acute, nonlethal effects Death Example: For healthy adults, is caffeine intake above 400 mg/day, compared to intakes of 400 mg/day or less, associated with acute adverse outcomes? * Comparators not identified by Nawrot et al for other populations 3
4 Characterization of Data for Acute Health Outcome Data Type Characterization Number of studies Study types* Populations 26 included; 20 excluded Case reports and case series Adults, pregnant women, adolescents Exposure Mostly self-reports with poor exposure characterization Voluntary and intentional consumption Few repeated exposures ~1/2 specifically evaluated caffeine (powder or tablet); others involved energy drinks or cola Outcome (Endpoints) Death, non-fatal effects associated with suicide attempts or high-dose related events (e.g., cardiovascular events; nausea; vomiting; seizures; hypokalemia) * Study types included only for acute endpoint on basis of rare effects 4
5 Considerations re: Fatal Doses For all drugs, published doses are not precise Data are based on observation, not on the scientific method Derived from case reports of suicide gestures where the dose history is unreliable Controlled studies are not possible These considerations also apply to establishing the adverse effect dose 5
6 Death The evidence demonstrates that in adolescents and adults, deaths occurred at doses mostly > 10g/day Most exposures were suicidal gestures Adverse effects in non-fatal cases included nausea, vomiting, and cardiovascular events Exposure characterization was poor Very low to low level of confidence in the body of evidence 6
7 Non-fatal Effects Most non-fatal effects of caffeine occurred at doses > 400 mg/day Reporting bias due to nature of study types (case studies associated with effects) Most exposures were NOT suicidal gestures Adverse effects typically included nausea, vomiting, hypokalemia, seizure, and cardiovascular events (e.g. tachycardia, palpitations, changes in blood pressure) Exposure characterization was poor Very low to low level of confidence in the body of evidence 7
8 Evaluation of Individual Study Quality (Risk of Bias) Overall high risk of bias for studies in adults; few qualified studies in other populations, none in children Limited greatly by exposure characterization Q8: Unintended Q11: Other, purity +2: Definitely low +1: Probably low -1: Probably high -2: Definitely high 8
9 Factors that increased or decreased confidence in the body of evidence by endpoint Endpoint No. of Studies Initial Confidence Rating Based on study type and study features (OHAT, 2015) Overall RoB Domain-based evaluation of risk of bias per the OHAT RoB tool (OHAT, 2015) Indirectness Was the study designed to evaluate the PECO? Magnitude Strength of effect (when effect observed below the comparator) Confounding Were plausible confounders that would change the observed effect accounted for? Consistency Were findings consistent in demonstrating effects or lack of effects at or below the comparator Final Confidence Rating What is the overall rating when factors that increase or decrease confidence were considered Death 14 Very low to low Not Evaluated /- Very low to low Other acute effects 18 Very low to low Not Evaluated /- Very low to low increased confidence - no change to confidence decreased confidence 9
10 Weight of Evidence Conclusion: Acute Adults: When the weight of evidence was considered, 400 mg caffeine/day (2.5 mg/kg/day for adolescents) was not associated with acute adverse effects. Wide range of adverse effects observed across cases, with overlap Death has been associated with acute exposures of 10g or more Only a single report of death following a dose less than 10g Acute effects may be a result of rapid consumption and do not represent typical consumer behavior Pregnant Women & Children: insufficient evidence to develop a conclusion 10
11 Future Research Needs Improved exposure characterization (i.e., testing of blood concentrations) 11
Cardiovascular Outcome
Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children: Cardiovascular Outcome D R. J E F F R E Y G O L D B E R G E R U
More informationBone and Calcium Outcome
Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children: Bone and Calcium Outcome D R. C O N N I E W E A V E R D E PA R T
More informationBehavior Outcome D R. H A R R I S L I E B E R M A N
Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children: Behavior Outcome D R. H A R R I S L I E B E R M A N M I L I TA R
More informationStriving for the Gold Standard in the Systematic Review Process
Striving for the Gold Standard in the Systematic Review Process ESTHER F MYERS, PHD, RDN, FAND EFMYERS@EFMYERSCONSULTING.COM APRIL 22, 2017 5/24/2017 1 Disclosures Past Chief Science Officer for Academy
More informationAdverse effects of caffeine after a single dose and after repeated doses consumed within a day
Adverse effects of caffeine after a single dose and after repeated doses consumed within a day Anders Sjödin Copenhagen University (Denmark) Chair of EFSA s WG on caffeine EFSA STAKEHOLDERS MEETING ON
More informationWORKSHEET: Etiology/Harm
Updated 9/10/2013 Name: WORKSHEET: Etiology/Harm Citation: McGregor SE, Courneya KS, Kopciuk KA, Tosevski C, Friedenreich CM. Case control study of lifetime alcohol intake and prostate cancer risk. Cancer
More informationA Risk/Benefit Approach to Assess Nutrient Intake: Do we Need a New DRI?
A Risk/Benefit Approach to Assess Nutrient Intake: Do we Need a New DRI? Alicia L. Carriquiry Iowa State University Collaborator: Suzanne Murphy, U. of Hawaii Disclosure statement I am a Distinguished
More informationActivities to Reduce Sodium Intake in the US: Overview
Activities to Reduce Sodium Intake in the US: Overview Christine L Taylor, PhD Retired (2006), US Food and Drug Administration Consultant, CLTaylor LLC Conflict of Interest Disclosure I have no conflict
More informationHigh5 Effervescent Tablets Zero 160g/40 Berry + caffeine
2139148 - High5 Effervescent Tablets Zero 160g/40 Berry + caffeine Food supplement with sweeteners and caffeine/berry flavour. Acidity regulators (E330, E296), sodium carbonate, sweeteners (E420, E955),
More informationSYNOPSIS (PROTOCOL WX17796)
TITLE OF THE STUDY A prospective, randomized, double-blind, placebo-controlled, parallel group, multicenter, 52-week trial to assess the efficacy and safety of adjunct MMF to achieve remission with reduced
More informationDhiren J. Naidu MD FRCPC Dip. Sport Med.
Dhiren J. Naidu MD FRCPC Dip. Sport Med. Associate Professor, Division of Physical Medicine & Rehabilitation Faculty of Medicine & Dentistry Varsity Health, University of Alberta Team Physician - Oilers,
More informationRisk Benefit Assessment. Cristina E. Torres, Ph.D. UP-NIH Faculty and FERCAP Coordinator
Risk Benefit Assessment Cristina E. Torres, Ph.D. UP-NIH Faculty and FERCAP Coordinator Definition of Risk The term risk refers both to the probability of a harm resulting from an activity and to its magnitude.
More informationNutrition and Cancer. Prof. Suhad Bahijri
Nutrition and Cancer Objectives 1. Discuss current knowledge regarding nutritional prevention of cancer 2. Discuss goals for the cancer patient 3. Explain how cancer treatment affects nutritional needs
More informationOverview and Comparisons of Risk of Bias and Strength of Evidence Assessment Tools: Opportunities and Challenges of Application in Developing DRIs
Workshop on Guiding Principles for the Inclusion of Chronic Diseases Endpoints in Future Dietary Reference Intakes (DRIs) Overview and Comparisons of Risk of Bias and Strength of Evidence Assessment Tools:
More informationHealth Products Regulatory Authority IPAR. Public Assessment Report for a. Traditional Herbal Medicinal Product
IPAR Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use Ginkgo-Biloba Pharma Nord film-coated tablets Ginkgo dry extract TR 1242/1/1 TR holder Pharma Nord ApS March 2018
More informationHepatitis E FAQs for Health Professionals
Hepatitis E FAQs for Health Professionals Index of Questions ± Overview and Statistics What is Hepatitis E? How common is Hepatitis E in the United States? Where is Hepatitis E most common? Are there different
More informationGlencoe Health. Lesson 3 Psychoactive Drugs
Glencoe Health Lesson 3 Psychoactive Drugs Health espotlight Video BIG IDEA Psychoactive drugs affect the central nervous system and can be especially damaging to the developing brain and body of a teen.
More informationTEST YOURSELF: Multiple Choice 1 QUESTIONS
1. In the investigation of an epidemic the most appropriate measure to describe the frequency of occurrence of illness is the: A. Prevalence B. Incidence rate C. Case-fatality rate D. Attack rate E. Mortality
More informationARTICLE REVIEW Article Review on Prenatal Fluoride Exposure and Cognitive Outcomes in Children at 4 and 6 12 Years of Age in Mexico
ARTICLE REVIEW Article Review on Prenatal Fluoride Exposure and Cognitive Outcomes in Children at 4 and 6 12 Years of Age in Mexico Article Link Article Supplementary Material Article Summary The article
More informationCannabis and cannabinoids for medicinal purposes
Cannabis and cannabinoids for medicinal purposes International Evidence and Evidence for Practice in Australia Michael Farrell Louisa Degenhardt, Wayne Hall, Nicholas Buckley, Megan Weir, Suzi Neilsen,
More informationPublic Assessment Report for a Traditional Herbal Medicinal Product for Human Use
IPAR Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use Ginkgoforce Memory & Circulation Ginkgo Tablets Extract (as dry extract) from fresh leaves of Ginkgo biloba (Ginkgo
More informationHigh5 Effervescent Tablets Zero X treme 80g/20 tablets Berry + Caffeine
720022 - High5 Effervescent Tablets Zero X treme 80g/20 tablets Berry + Caffeine Food supplement with sweeteners and caffeine/berry flavour. Acidity regulators (E330, E296), sodium carbonate, sweeteners
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 05 May 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 05 May 2010 LAMICTAL 2 mg, dispersible / chewable tablet B/30 (CIP: 354 581-7) LAMICTAL 5 mg, dispersible / chewable
More informationTeotard Teotard 200 mg prolonged release capsule, hard
PACKAGE LEAFLET: INFORMATION FOR THE USER Teotard Teotard 200 mg prolonged release capsule, hard Teotard 350 mg prolonged release capsule, hard THEOPHYLLINE This leaflet is a copy of the Summary of Product
More informationCausation Assessment and Methodology
Causation Assessment and Methodology Kurt T. Hegmann, MD, MPH University of Utah Content Attestation I, Kurt Hegmann, MD hereby declare that the content for this activity, including any presentation of
More informationINITIAL PATIENT INTAKE FORM
INITIAL PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: MM / DD / YYYY Gender: Male Female Address: Town: State: Zip Code: Preferred method of contact. For internal promotional use only.
More informationPrevalence and Impact of Caffeine Consumption among Adolescents
Prevalence and Impact of Caffeine Consumption among Adolescents Roland Griffiths, a leading expert on caffeine at Johns Hopkins University notes that "Caffeine is the most widely used mood altering drug
More informationDevelopment of NJ Human Health-based Criteria and Standards
Development of NJ Human Health-based Criteria and Standards Gloria Post NJDEP Office of Science Presented to: Public Health Standing Committee October 18, 2010 Human Health-based Criteria and Standards
More informationWashington, DC, November 9, 2009 Institute of Medicine
Holger Schünemann, MD, PhD Chair, Department of Clinical Epidemiology & Biostatistics Michael Gent Chair in Healthcare Research McMaster University, Hamilton, Canada Washington, DC, November 9, 2009 Institute
More informationMeningococcal Disease and College Students
MASSACHUSETTS PUBLIC HEALTH FACT SHEET Meningococcal Disease and College Students May 2018 Page 1 of 4 What is meningococcal disease? Meningococcal disease is caused by infection with bacteria called Neisseria
More informationApproaches to Integrating Evidence From Animal and Human Studies in Chemical Assessments
Approaches to Integrating Evidence From Animal and Human Studies in Chemical Assessments Kris Thayer, National Center for Environmental Assessment (NCEA) Integrated Risk Information System (IRIS) Division
More informationScottish Medicines Consortium
Scottish Medicines Consortium olanzapine 210mg, 300mg, 405mg powder and solvent for prolonged release suspension for injection (ZypAdhera ) No. (624/10) Eli Lilly and Company Limited 09 July 2010 The Scottish
More information11 questions to help you make sense of a case control study
Critical Appraisal Skills Programme (CASP) making sense of evidence 11 questions to help you make sense of a case control study How to use this appraisal tool Three broad issues need to be considered when
More informationBRL /RSD-101RLL/1/CPMS-716. Report Synopsis
Report Synopsis Study Title: A Multicenter, Open-label, Six-Month Extension Study to Assess the Long-term Safety of Paroxetine in Children and Adolescents with Major Depressive Disorder (MDD) or Obsessive-Compulsive
More informationBRL /RSD-101C0D/1/CPMS-704. Report Synopsis
Report Synopsis Study Title: A Randomized, Multicenter, 10-Week, Double-Blind, Placebo- Controlled, Flexible-Dose Study to Evaluate the Efficacy and Safety of Paroxetine in Children and Adolescents with
More informationREST & RECOVERY.
REST & RECOVERY www.thefitnessexperts.co.uk Medical Disclaimer Always consult your medical practitioner, registered dietician or nutritionist before making any significant changes to your diet particularly
More informationHeadaches. Mini Medical School. November 10, A. Laine Green MSc, MD FRCP(C) Assistant Professor Department of Medicine (Neurology)
Headaches. Mini Medical School. November 10, 2016 A. Laine Green MSc, MD FRCP(C) Assistant Professor Department of Medicine (Neurology) Artist Agnes Cecile Disclosures I have received an honorarium from
More informationMonitoring, Evaluation, Accountability, Learning (MEAL) Enabling Environment Finance for. Nutrition
Monitoring, Evaluation, Accountability, Learning (MEAL) 2016 2020 COUNTRY DASHBOARD Country A COUNTRY A The Country Dashboard provides an overview on the progress using a standard set of indicators that
More informationStudy Center(s): The study was conducted at 39 study sites in Japan.
SYNOPSIS Issue Date: 20 NOVEMBER 2012 Name of Sponsor/Company Janssen Pharmaceutical K. K. Name of Finished Product CONCERTA Name of Active Ingredient(s) Methylphenidate HCl Protocol No.: JNS001-JPN-A01
More informationREVISED. Tulare County 2007
Indicators of Alcohol and Other Drug Risk and Consequences for California Counties REVISED Tulare County 2007 Indicators of Alcohol and Other Drug Risk and Consequences for California Counties Tulare County
More informationHealthy carbohydrates: Challenges in dietary guidance. Joanne Slavin Professor Department of Food Science and Nutrition October 26, 2015
Healthy carbohydrates: Challenges in dietary guidance Joanne Slavin Professor Department of Food Science and Nutrition October 26, 2015 From the Science to Me The Science Policy Me There is no perfect
More informationARTICLE REVIEW Article Review on Prenatal Fluoride Exposure and Cognitive Outcomes in Children at 4 and 6 12 Years of Age in Mexico
ARTICLE REVIEW Article Review on Prenatal Fluoride Exposure and Cognitive Outcomes in Children at 4 and 6 12 Years of Age in Mexico Article Summary The article by Bashash et al., 1 published in Environmental
More informationDifferences in risky behaviors between non-drinkers & current drinkers in Michigan youth
Differences in risky behaviors between non-drinkers & current drinkers in Michigan youth - 9 Katy Gonzales, MPH Alcohol Epidemiologist Michigan Department of Community Health April 1, 11 Youth Risk Behavior
More informationWARNING LETTER. Robert Essner Chairman and Chief Executive Officer Wyeth Pharmaceuticals Inc. P.O. Box 8299 Philadelphia, PA
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857 TRANSMITTED BY FACSIMILE Robert Essner Chairman and Chief Executive Officer P.O. Box 8299 Philadelphia,
More informationMicafungin, a new Echinocandin: Pediatric Development
Micafungin, a new Echinocandin: Pediatric Development Andreas H. Groll, M.D. Infectious Disease Research Program Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology University
More information2018 Warren County Local Assessment (MCH Grant) Summary
2018 Warren County Local Assessment (MCH Grant) Summary Maternal Child Health Population Assessment What we looked at Warren County Data from reliable sources- (Federal, State and Local) Interviews & feedback
More informationLow-fat Diets for Long-term Weight Loss What Do Decades of Randomized Trials Conclude?
Low-fat Diets for Long-term Weight Loss What Do Decades of Randomized Trials Conclude? HSPH Nutrition Department Seminar Series October 5, 2015 Deirdre Tobias, ScD Instructor of Medicine Harvard Medical
More informationExperimental Biology 2017
Experimental Biology 2017 The Caffeine Landscape April 22, 2017 Dennis Keefe, PhD Director Office of Food Additive Safety U.S. Food and Drug Administration Nawrot et al. 2003 1 Endpoints reviewed General
More informationName of the Substance
Name of the Substance 0. Do you have any information on the use of this substance in your country either for medical, scientific, industrial or other professional purposes, for non-medical consumption
More informationOnline Supplementary Material
Section 1. Adapted Newcastle-Ottawa Scale The adaptation consisted of allowing case-control studies to earn a star when the case definition is based on record linkage, to liken the evaluation of case-control
More informationCRITICAL APPRAISAL SKILLS PROGRAMME Making sense of evidence about clinical effectiveness. 11 questions to help you make sense of case control study
CRITICAL APPRAISAL SKILLS PROGRAMME Making sense of evidence about clinical effectiveness 11 questions to help you make sense of case control study General comments Three broad issues need to be considered
More informationBEER AND CARDIOVASCULAR HEALTH: EFFECTS ON MORBIDITY AND MORTALITY. Simona Costanzo THE 7 TH EUROPEAN BEER AND HEALTH SYMPOSIUM
BEER AND CARDIOVASCULAR HEALTH: EFFECTS ON MORBIDITY AND MORTALITY Simona Costanzo Department of Epidemiology and Prevention IRCCS Mediterranean Neurological Institute Pozzilli (IS), Italy simona.costanzo@neuromed.it
More informationTreatment of Influenza. Dr. YU Wai Cho
Treatment of Influenza Dr. YU Wai Cho Symptomatic Treatment Analgesics/ Antipyretics (avoid aspirin) Adequate fluids Rest Specific Drug Treatment Synthetic amines Amantadine Rimantadine Neuraminidase inhibitors
More informationHealtheCNY Indicator List by Data Source
American Community Survey 23 Adults with Health Insurance Children Living Below Poverty Level Children with Health Insurance Families Living Below Poverty Level Homeowner Vacancy Rate Homeownership Households
More informationCardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: METHYLPHENIDATE Protocol number: CV 42
Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE Drug: METHYLPHENIDATE Protocol number: CV 42 Indication: ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), HYPERKINETIC
More informationGENder Education and Care Interdisciplinary Support (GENECIS) Feminizing Medications for Patients with Gender Dysphoria
GENder Education and Care Interdisciplinary Support (GENECIS) Feminizing Medications for Patients with Gender Dysphoria Patient Information and Informed Consent and Assent for Minors Before using medications
More informationPackage leaflet: Information for the patient. Selincro 18 mg film-coated tablets nalmefene
Package leaflet: Information for the patient Selincro 18 mg film-coated tablets nalmefene Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationINTRODUCTION: DEFINITION OF HEAT ILLNESS:
Coastal Carolina University Athletic Training Department Policy and Procedure Manual Exertional Heat Illness Management Fluid Replacement/Rehydration Protocol Revised/Reviewed 3/2013 INTRODUCTION: The
More informationCONCUSSION/HEAD INJURY AND HEAT ILLNESS GUIDELINES
CONCUSSION/HEAD INJURY AND HEAT ILLNESS GUIDELINES WHAT IS A CONCUSSION? A concussion is a type of traumatic brain injury caused by a bump, blow, or jolt to the head, or by a blow to the body with the
More informationDeterminants of quality: Factors that lower or increase the quality of evidence
Determinants of quality: Factors that lower or increase the quality of evidence GRADE Workshop CBO, NHG and Dutch Cochrane Centre CBO, April 17th, 2013 Outline The GRADE approach: step by step Factors
More informationMetabolic monitoring in the ICU
Metabolic monitoring in the ICU Jean-Daniel Chiche, MD PhD MICU & Dept of Host-Pathogen Interaction Hô pital Cochin & Institut Cochin, Paris-F Conflicts of interest - Disclosure GE Healthcare Received
More informationNUTRITIONAL SUPPLEMENTS IN OBESITY: WHAT ARE THEY, DO THEY WORK, & ARE THEY SAFE?
NUTRITIONAL SUPPLEMENTS IN OBESITY: WHAT ARE THEY, DO THEY WORK, & ARE THEY SAFE? Stephanie Nichols, Pharm.D., BCPS, BCPP Associate Professor of Psychiatric Pharmacy Husson University, Bangor Maine 1968
More informationPrevious Study Return to List Next Study
A service of the U.S. National Institutes of Health Trial record 1 of 1 for: 42603ATT3013 Previous Study Return to List Next Study A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS
More informationConfounding and Interaction
Confounding and Interaction Why did you do clinical research? To find a better diagnosis tool To determine risk factor of disease To identify prognosis factor To evaluate effectiveness of therapy To decide
More informationMadagascar. Monitoring, Evaluation, Accountability, Learning (MEAL) COUNTRY DASHBOARD MADAGASCAR
Monitoring, Evaluation, Accountability, Learning (MEAL) 2016 2020 COUNTRY DASHBOARD Madagascar The MEAL Results Framework identifies a wide range of desired results and associated indicators of progress
More informationThe road to evidencebased. recommendations for flavonoids: how do we get there? Douglas Balentine, PhD Unilever 19 October 2013
The road to evidencebased dietary recommendations for flavonoids: how do we get there? Douglas Balentine, PhD Unilever 19 October 2013 The International Life Sciences Institute (ILSI) ILSI improves human
More informationDemocratic Republic of Congo
Monitoring, Evaluation, Accountability, Learning (MEAL) 2016 2020 COUNTRY DASHBOARD Democratic Republic of Congo The MEAL Results Framework identifies a wide range of desired results and associated indicators
More informationGLUCOPHAGE 500 mg Merck Serono
GLUCOPHAGE 500 mg Film-coated tablets Composition Film-coated tablets containing 500 mg of metformin (INN) hydrochloride (equivalent to 390 mg of metformin Excipients Polyvidone K 30, magnesium stearate,
More informationMonitoring, Evaluation, Accountability, Learning (MEAL) Enabling Environment Finance for. Nutrition
Monitoring, Evaluation, Accountability, Learning (MEAL) 2016 2020 COUNTRY DASHBOARD Philippines The MEAL Results Framework identifies a wide range of desired results and associated indicators of progress
More informationCentral African Republic
Monitoring, Evaluation, Accountability, Learning (MEAL) 2016 2020 COUNTRY DASHBOARD The MEAL Results Framework identifies a wide range of desired results and associated indicators of progress across various
More informationHealthy Bones. How much calcium do I need each day? What can I do to keep my bones strong and healthy? How much vitamin D do I need each day?
Healthy Bones Building and keeping strong, healthy bones continues throughout a person's life. Bones have many important roles in the body. They support your body, protect organs, help muscles work, and
More informationFile NDA SE5 046/047, NDA SE5 036/037, NDA SE5 020/021
M E M O R A N D U M DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH DATE: 18 June 2007 FROM: TO: SUBJECT: Mitchell V.
More informationBournemouth, Dorset and Poole Prescribing Forum
SHARED CARE GUIDELINES FOR PRESCRIBING OF METHYLPHENIDATE IN ATTENTION DEFICIT HYPERACTIVITY DISORDER IN CHILDREN INDICATION Methylphenidate is generally regarded as a first line choice of treatment for
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationMonitoring, Evaluation, Accountability, Learning (MEAL) Enabling Environment Finance for. Nutrition
Monitoring, Evaluation, Accountability, Learning (MEAL) 2016 2020 COUNTRY DASHBOARD Togo The MEAL Results Framework identifies a wide range of desired results and associated indicators of progress across
More informationDrug Class Review Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder
Drug Class Review Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder Final Report Update 3 September 2009 Update 2: November 2007 Update 1: May 2006 Original Report: September 2005 The
More informationBETTER YOUR BONES UPDATE ON LATEST BONE HEALTH RESEARCH
BETTER YOUR BONES UPDATE ON LATEST BONE HEALTH RESEARCH Taylor C. Wallace, PhD, CFS, FACN Academy of Nutrition and Dietetics Food Nutrition Conference & Expo October 5 th, 2015 Disclosures Employment George
More informationPFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See United States Package Insert (USPI)
PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.
More informationSmoking cessation therapy
Appendix 1 Smoking cessation therapy Q. Can a dentist prescribe medications for smoking cessation? A. Yes. Dentists are allowed and are encouraged to help patients with smoking cessation by counseling
More informationChapter 03: Sinus Mechanisms Test Bank MULTIPLE CHOICE
Instant download and all chapters Tesst Bank ECGs Made Easy 5th Edition Barbara J Aehlert https://testbanklab.com/download/tesst-bank-ecgs-made-easy-5th-edition-barbara-jaehlert/ Chapter 03: Sinus Mechanisms
More informationMonitoring, Evaluation, Accountability, Learning (MEAL) Enabling Environment Finance for. Nutrition
Monitoring, Evaluation, Accountability, Learning (MEAL) 2016 2020 COUNTRY DASHBOARD El Salvador The MEAL Results Framework identifies a wide range of desired results and associated indicators of progress
More informationWhy is ILCOR moving to GRADE?
1 Why is ILCOR moving to GRADE? Associate Professor Peter Morley Director Medical Education Royal Melbourne Hospital University of Melbourne 10 min 2 3 4 5 6 7 Apart from international consensus Allows
More informationPFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See United States Package Insert (USPI)
PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.
More informationConsolidated Project Information Project 4.a.ii Substance Abuse Prevention and Identification Initiative
Consolidated Project Information Project 4.a.ii Substance Abuse Prevention and Identification Initiative Contents 4.a.ii Prevent Substance Abuse and Other Mental Emotional Disorders (Focus Area 2)... 3
More informationIndiana Soccer Hot Weather Recommendations. In all cases, age group and competitive level must be taken into consideration.
Indiana Soccer Hot Weather Recommendations In all cases, age group and competitive level must be taken into consideration. I. HEAT INDEX Heat Index can be described as what it feels like outside. By definition,
More informationAn Introduction To Atrial Fibrillation: What You Need To Know
An Introduction To Atrial Fibrillation: What You Need To Know If you ve ever felt like your heart has a difficult time maintaining a regular rhythm, or you find yourself gasping for air while your heart
More informationMonitoring, Evaluation, Accountability, Learning (MEAL) Enabling Environment Finance for. Nutrition
Monitoring, Evaluation, Accountability, Learning (MEAL) 2016 2020 COUNTRY DASHBOARD Kyrgyzstan The MEAL Results Framework identifies a wide range of desired results and associated indicators of progress
More informationUganda. Monitoring, Evaluation, Accountability, Learning (MEAL) COUNTRY DASHBOARD UGANDA
Monitoring, Evaluation, Accountability, Learning (MEAL) 2016 2020 COUNTRY DASHBOARD Uganda The MEAL Results Framework identifies a wide range of desired results and associated indicators of progress across
More informationLow-calorie sweeteners and weight a systematic review of human and animal studies
Low-calorie sweeteners and weight a systematic review of human and animal studies Peter J Rogers School of Experimental Psychology University of Bristol, UK IUNS-ICN 21 st International Congress on Nutrition,
More informationPapua New Guinea. Monitoring, Evaluation, Accountability, Learning (MEAL) COUNTRY DASHBOARD PAPUA NEW GUINEA
Monitoring, Evaluation, Accountability, Learning (MEAL) 2016 2020 COUNTRY DASHBOARD The MEAL Results Framework identifies a wide range of desired results and associated indicators of progress across various
More informationStudy No.: Title: Rationale: Phase Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationIntroduzione al metodo GRADE
Introduzione al metodo GRADE Atto Billio MD, MSc EBHC Ematologia e TMO-Bolzano Gruppo linee guida SIE Critique of EBM De-emphasizes patient values Doesn t account for individual variation Devalues clinical
More informationCONSORT 2010 checklist of information to include when reporting a randomised trial*
Supplemental Figures for: Ramosetron Versus Ondansetron in Combination with Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-induced Nausea and Vomiting: A Multicenter,
More informationSetting The setting was primary care. The economic analysis was conducted in Glasgow, UK.
Helicobacter pylori eradication for peptic ulceration: an observational study in a Scottish primary care setting Forrest E H, MacKenzie J F, Stuart R C, Morris A J Record Status This is a critical abstract
More informationThe clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.
The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. Please note that the results reported in any single trial may not reflect the overall
More informationAnne M. Calkins, 1 Joseph Shurman, 2 Mark Jaros, 3 Richard Kim, 4 Gwendoline Shang 4. New York Spine and Wellness Center, North Syracuse, NY; 2
Peripheral Edema and Weight Gain in Adult Patients With Painful Diabetic Peripheral Neuropathy Receiving Gabapentin Enacarbil or Pregabalin Enrolled in a Randomized, Phase 2 Trial Anne M. Calkins, 1 Joseph
More informationNTP RESEARCH REPORT SYSTEMATIC LITERATURE REVIEW ON THE EFFECTS OF FLUORIDE MEMORY IN ANIMAL STUDIES ON LEARNING AND NTP RR 1
NTP RESEARCH REPORT SYSTEMATIC LITERATURE REVIEW ON THE EFFECTS OF FLUORIDE ON LEARNING AND MEMORY IN ANIMAL STUDIES NTP RR 1 JULY 2016 Systematic Literature Review on the Effects of Fluoride on Learning
More informationRead all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Package leaflet: Information for the patient Hedelix Effervescent Tablets Active substance: ivy leaf dry extract Read all of this leaflet carefully before you start taking this medicine because it contains
More informationBupropion HCl, bupropion hydrobromide Wellbutrin SR, Wellbutrin XL, Zyban, Aplenzin, Forfivo XL
Bupropion Generic names Available brands Available strengths and formulations Available in generic Bupropion HCl, bupropion hydrobromide Wellbutrin SR, Wellbutrin XL, Zyban, Aplenzin, Forfivo XL 75-mg
More informationILMC Tool Box Series 4.6. General Population and Community Issues. Health Issues for Lead Workers and the General Population. 1.
For non-occupationally exposed populations, blood lead levels are generally reflective of lead exposure from multiple environmental media. Once again, relationships between exposure level and subsequent
More information